DE2131193A1 - Arzneimittelzubereitung - Google Patents
ArzneimittelzubereitungInfo
- Publication number
- DE2131193A1 DE2131193A1 DE19712131193 DE2131193A DE2131193A1 DE 2131193 A1 DE2131193 A1 DE 2131193A1 DE 19712131193 DE19712131193 DE 19712131193 DE 2131193 A DE2131193 A DE 2131193A DE 2131193 A1 DE2131193 A1 DE 2131193A1
- Authority
- DE
- Germany
- Prior art keywords
- methyl
- pyrrole
- nitro
- aldehyde
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1123770 | 1970-07-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2131193A1 true DE2131193A1 (de) | 1972-01-27 |
Family
ID=4371472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712131193 Pending DE2131193A1 (de) | 1970-07-24 | 1971-06-23 | Arzneimittelzubereitung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3705249A (https=) |
| BE (1) | BE770400A (https=) |
| DE (1) | DE2131193A1 (https=) |
| FR (1) | FR2100947B1 (https=) |
| GB (1) | GB1305179A (https=) |
| IL (1) | IL37233A (https=) |
| NL (1) | NL7109769A (https=) |
| ZA (1) | ZA714029B (https=) |
-
1971
- 1971-06-21 ZA ZA714029A patent/ZA714029B/xx unknown
- 1971-06-23 DE DE19712131193 patent/DE2131193A1/de active Pending
- 1971-07-05 IL IL37233A patent/IL37233A/xx unknown
- 1971-07-15 NL NL7109769A patent/NL7109769A/xx unknown
- 1971-07-16 US US163442A patent/US3705249A/en not_active Expired - Lifetime
- 1971-07-22 FR FR7126839A patent/FR2100947B1/fr not_active Expired
- 1971-07-23 BE BE770400A patent/BE770400A/xx unknown
- 1971-07-23 GB GB3475771A patent/GB1305179A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1305179A (https=) | 1973-01-31 |
| FR2100947B1 (https=) | 1974-09-06 |
| FR2100947A1 (https=) | 1972-03-24 |
| BE770400A (fr) | 1972-01-24 |
| IL37233A0 (en) | 1971-10-20 |
| NL7109769A (https=) | 1972-01-26 |
| IL37233A (en) | 1974-06-30 |
| ZA714029B (en) | 1972-03-29 |
| US3705249A (en) | 1972-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69521799T2 (de) | Polymer umhüllte tablette enthaltend amoxicillin und clavulanat | |
| DE2813480C2 (de) | Arzneimittel-Depotpräparat vom Mehrfacheinheitsdosen-Typ | |
| AT409083B (de) | Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung | |
| DE69009684T2 (de) | Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen. | |
| DE1617374A1 (de) | Verfahren zum Herstellen eines pharmazeutischen Praeparates mit verzoegerter Wirkung | |
| DE69111574T2 (de) | Polycarbophil-Kalzium enthaltendes Arzneimittel. | |
| DE69420776T2 (de) | Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer | |
| DE3343934A1 (de) | M-chlor-(alpha)-tert.-butylaminopropiophenon und seine verwendung zur senkung des cholesterolspiegels | |
| DE69433012T2 (de) | Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac | |
| EP0427124B1 (de) | Antacidatabletten | |
| DE68910676T2 (de) | Verwendung von Creosot als antispastischer Wirkstoff. | |
| DE2259646A1 (de) | Hochdosierte tabletten von cephalosporin-derivaten sowie verfahren zu ihrer herstellung | |
| DE2251250A1 (de) | Verfahren zur herstellung hochdosierter antibiotica-tabletten | |
| DE10392164T5 (de) | Oral verabreichbare pharmazeutische Formulierung | |
| DE2823655A1 (de) | Arzneimittel zur behandlung von bakteriellen affekten | |
| DE3417576A1 (de) | Retardformen des alpha-(2,5-dimethoxy-phenyl)-ss-glycinamidoaethanols und verfahren zu ihrer herstellung | |
| DE2715384C3 (de) | Arzneimittel gegen Diarrhöen | |
| DE2131193A1 (de) | Arzneimittelzubereitung | |
| CH648209A5 (de) | Arzneimittelkombination zur behandlung infektioeser atemwegserkrankungen. | |
| DE2347531A1 (de) | Arzneizubereitungen zur oralen diabetes-behandlung | |
| DE2250032A1 (de) | Arzneimittel auf der basis von lysinderivaten zur bekaempfung von leukopenien und anomalien der weissen blutkoerperchen unterschiedlicher aetiologie | |
| DE2621906C2 (https=) | ||
| DE69701139T2 (de) | Verwendung von lofexidin zur herstellung eines arzneimittels zur behandkung der mit konzentrationsschwäche einhergehenden hyperaktivität | |
| DE1913738C3 (de) | Arzneimittel zur Behandlung von neurotischen Angstzuständen | |
| DE2307251A1 (de) | Therapeutikum fuer chronische obstipation und leberschaeden |